Dr. Elson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-996-9113
Education & Training
- University of ChicagoFellowship, Gastroenterology, 1972 - 1975
- University of ChicagoResidency, Internal Medicine, 1972 - 1975
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1968 - 1970
- Washington University in St. Louis School of MedicineClass of 1968
Certifications & Licensure
- AL State Medical License 1988 - 2024
- VA State Medical License 1978 - 2000
- IL State Medical License 1972 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 626 citationsAnti-interleukin-12 antibody for active Crohn's diseasePeter J. Mannon, Ivan J. Fuss, Lloyd Mayer, Charles O. Elson, William J. Sandborn
The New England Journal of Medicine. 2004-11-11 - 73 citationsLow-dose oral methotrexate in refractory inflammatory bowel disease.Todd H. Baron, Christopher Truss, Charles O. Elson
Digestive Diseases and Sciences. 1993-10-01 - 256 citationsCholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigenCharles O. Elson, W Ealding
Journal of Immunology. 1984-12-01
Press Mentions
- As U.S. Corporations Face Reckoning over Prescription Opioids, CEOs Keep Cashing InMarch 29th, 2021
- U.S. Corporations Face Reckoning over Prescription Opioids, CEOs Keep Cashing InMarch 28th, 2021
Grant Support
- Innate And Adaptive Immunity To Microbial Flagellins In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Innate And Adaptive Immunity In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Animal Model CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Innate And Adaptive Microbial Immunity In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Innate An Adaptive Immunity To Microbial Flagellins In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Core--Animal ModelNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- UAB Autoimmunity Center For ExcellenceNational Institute Of Allergy And Infectious Diseases2007
- Intestinal T-Regulatory-1 Cells In Mucosal HomeostasisNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- AdministrativeNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Chronic Intestinal Inflammation--Mechanisms And EffectsNational Institute Of Diabetes And Digestive And Kidney Diseases1991–2003
- 11th International Congress Of Mucosal ImmunologyNational Institute Of Allergy And Infectious Diseases2002
- Core--Animal ModelNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Studies Of Oral Tolerance In ManNational Center For Research Resources1996–2002
- T Cell Receptors And Epitopes In Chronic ColitisNational Institute Of Diabetes And Digestive And Kidney Diseases1991–2002
- IV Azathioprine Loading To Decrease Response Time In Steroid Refractory CrohnsNational Center For Research Resources1998–1999
- Mucosal Tolerance And ImmunityNational Institute Of Allergy And Infectious Diseases1994–1998
- Core--Animal Model FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1998
- Sch52000 Multiple Dose SC Safety In Mild To Moderate Crohns DiseaseNational Center For Research Resources1997
- Sch52000 Multiple Dose SC In Mild To Moderate Ulcerative ColitisNational Center For Research Resources1997
- T Cell Repertoire In Murine ColitisFogarty International Center1997
- Anti TNF Chimeric Monoclonal Antibody 9ca2 In Active Crohns DiseaseNational Center For Research Resources1996–1997
- IV Rhuil10 In Steroid Refractory Crohns DiseaseNational Center For Research Resources1996
- Chimeric Anti-Tnf Monoclonal Antibody In Active Crohns DiseaseNational Center For Research Resources1996
- Regulation Of Intestinal Immune ResponsesNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993
- Animal Model CoreNational Institute Of Diabetes And Digestive And Kidney Diseases1991
- Scientific Review &Evaluation AwardNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1988
- Intestinal Immunoregulation: Inflammatory Bowel DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1988
- Regulation Of Intestinal Immune ResponsesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
- Intestinal Immunoregulation: Inflammatory Bowel DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
- Regulation Of Intestinal Immune ResponsesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Intestinal Immunoregulation: Inflammatory Bowel DiseaseNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Gastrointestinal ImmunologyNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: